| 355138 |
--- |
April 25 2025 02:25:22. |
0755 |
|
|
| 2017(1)(1).pdf |
3.64 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| 2017(1).pdf |
3.64 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| 2017(2).pdf |
3.64 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| 2017.pdf |
3.64 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| 2018(1)(1).pdf |
2.63 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| 2018(1).pdf |
2.63 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| 2018(2).pdf |
2.63 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| 2018.pdf |
2.63 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| 2019(1)(1).pdf |
3.11 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| 2019(1).pdf |
3.11 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| 2019(2).pdf |
3.11 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| 2019-20(1)(1).pdf |
7.68 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| 2019-20(1).pdf |
7.68 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| 2019-20(2).pdf |
7.68 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| 2019-20.pdf |
7.68 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| 2019.pdf |
3.11 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| 44793 - SFDA.pdf |
66.49 KB |
July 15 2025 10:50:02. |
0644 |
|
|
| ANNUAL-REPORT-2021-22-FINAL(1)(1).pdf |
2.35 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| ANNUAL-REPORT-2021-22-FINAL(1).pdf |
2.35 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| ANNUAL-REPORT-2021-22-FINAL(2).pdf |
2.35 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| ANNUAL-REPORT-2021-22-FINAL.pdf |
2.35 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| ANNUAL_REPORT 2021-22(1)(1).pdf |
1.79 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| ANNUAL_REPORT 2021-22(1).pdf |
1.79 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| ANNUAL_REPORT 2021-22(2).pdf |
1.79 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| ANNUAL_REPORT 2021-22.pdf |
1.79 MB |
December 20 2022 08:35:41. |
0644 |
|
|
| Artwork-Remdesivir-100mg(1)(1).pdf |
869.94 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Artwork-Remdesivir-100mg(1).pdf |
869.94 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| Artwork-Remdesivir-100mg(2).pdf |
869.94 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Artwork-Remdesivir-100mg.pdf |
869.94 KB |
June 23 2022 11:06:13. |
0644 |
|
|
| Artwork-Remdesivir-150mg(1)(1).pdf |
889.01 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Artwork-Remdesivir-150mg(1).pdf |
889.01 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| Artwork-Remdesivir-150mg(2).pdf |
889.01 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Artwork-Remdesivir-150mg.pdf |
889.01 KB |
June 23 2022 11:06:13. |
0644 |
|
|
| BETA LECTUM 03.07.2024(1)(1).xlsx |
17.66 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| BETA LECTUM 03.07.2024(1).xlsx |
17.66 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| BETA LECTUM 03.07.2024(2).xlsx |
17.66 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| BETA LECTUM 03.07.2024.docx.pdf |
396.08 KB |
July 15 2025 07:19:48. |
0644 |
|
|
| BETA LECTUM 03.07.2024.xlsx |
17.66 KB |
July 10 2024 10:36:18. |
0644 |
|
|
| BPM PERU.pdf |
413.31 KB |
September 26 2024 04:54:22. |
0644 |
|
|
| Botswana.pdf |
1.93 MB |
July 19 2025 11:58:35. |
0644 |
|
|
| CEPHALOSPORINS PRODUCT LIST 03.07.2024(1)(1).xlsx |
16.63 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| CEPHALOSPORINS PRODUCT LIST 03.07.2024(1).xlsx |
16.63 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| CEPHALOSPORINS PRODUCT LIST 03.07.2024(2).xlsx |
16.63 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| CEPHALOSPORINS PRODUCT LIST 03.07.2024.pdf |
294.54 KB |
July 15 2025 07:17:11. |
0644 |
|
|
| CEPHALOSPORINS PRODUCT LIST 03.07.2024.xlsx |
16.63 KB |
July 10 2024 10:36:18. |
0644 |
|
|
| CP Approval 206-NMRA-MP-421.pdf |
522.14 KB |
February 14 2026 08:49:02. |
0644 |
|
|
| Cephalo sterile Anvisa(1)(1).pdf |
287.80 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Cephalo sterile Anvisa(1).pdf |
287.80 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| Cephalo sterile Anvisa(2).pdf |
287.80 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Cephalo sterile Anvisa.pdf |
287.80 KB |
November 15 2023 05:22:36. |
0644 |
|
|
| Certificate of Incorporation(1)(1).pdf |
324.19 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Certificate of Incorporation(1).pdf |
324.19 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| Certificate of Incorporation(2).pdf |
324.19 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Certificate of Incorporation.pdf |
324.19 KB |
November 15 2023 05:25:26. |
0644 |
|
|
| EU-GMP-Kwality(1)(1).pdf |
569.49 KB |
August 30 2024 05:35:37. |
0755 |
|
|
| EU-GMP-Kwality(1).pdf |
569.49 KB |
August 30 2024 05:35:05. |
0755 |
|
|
| EU-GMP-Kwality(2).pdf |
569.49 KB |
August 30 2024 05:35:37. |
0755 |
|
|
| EU-GMP-Kwality.pdf |
569.49 KB |
July 26 2023 05:22:43. |
0755 |
|
|
| GENERAL PRODUCT LIST . 03.07.2024(1)(1).xlsx |
105.94 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| GENERAL PRODUCT LIST . 03.07.2024(1).xlsx |
105.94 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| GENERAL PRODUCT LIST . 03.07.2024(2).xlsx |
105.94 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| GENERAL PRODUCT LIST . 03.07.2024.pdf |
1.50 MB |
July 15 2025 07:17:30. |
0644 |
|
|
| GENERAL PRODUCT LIST . 03.07.2024.xlsx |
105.94 KB |
July 10 2024 10:36:18. |
0644 |
|
|
| GLP-Certificate-NEW-2020-21(1)(1).pdf |
326.83 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| GLP-Certificate-NEW-2020-21(1).pdf |
326.83 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| GLP-Certificate-NEW-2020-21(2).pdf |
326.83 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| GLP-Certificate-NEW-2020-21.pdf |
326.83 KB |
June 23 2022 11:06:13. |
0644 |
|
|
| GMP Certificate Kwality Pharmaceuticals NAFDAC(1)(1).pdf |
577.12 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| GMP Certificate Kwality Pharmaceuticals NAFDAC(1).pdf |
577.12 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| GMP Certificate Kwality Pharmaceuticals NAFDAC(2).pdf |
577.12 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| GMP Certificate Kwality Pharmaceuticals NAFDAC.pdf |
577.12 KB |
November 15 2023 05:15:59. |
0644 |
|
|
| GMP of Bulgaria.pdf |
141.53 KB |
February 10 2025 06:11:48. |
0644 |
|
|
| Ghana GMP.pdf |
217.79 KB |
July 19 2025 11:55:43. |
0644 |
|
|
| INDIA - GLP Certificate 12.04.2018(1)(1).pdf |
294.23 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| INDIA - GLP Certificate 12.04.2018(1).pdf |
294.23 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| INDIA - GLP Certificate 12.04.2018(2).pdf |
294.23 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| INDIA - GLP Certificate 12.04.2018.pdf |
294.23 KB |
June 23 2022 11:06:13. |
0644 |
|
|
| INVIMA Certificate AMRITSAR.pdf |
460.00 KB |
July 24 2025 08:42:19. |
0644 |
|
|
| INVIMA Certificate HP.pdf |
310.73 KB |
July 24 2025 08:42:20. |
0644 |
|
|
| Ivory Coast - GMP KWALITY PHARMACEUTICALS Ivory Coast Oct 11 2017(1)(1).pdf |
3.31 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| Ivory Coast - GMP KWALITY PHARMACEUTICALS Ivory Coast Oct 11 2017(1).pdf |
3.31 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| Ivory Coast - GMP KWALITY PHARMACEUTICALS Ivory Coast Oct 11 2017(2).pdf |
3.31 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| Ivory Coast - GMP KWALITY PHARMACEUTICALS Ivory Coast Oct 11 2017.pdf |
3.31 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| KPL Global Development Product list.pdf |
2.77 MB |
October 09 2025 12:47:52. |
0644 |
|
|
| KPL Ready Dossier Product list.pdf |
14.01 MB |
October 09 2025 12:48:07. |
0644 |
|
|
| Kwality Amritsar Unit I GMP Closure letter zimbabw.pdf |
75.39 KB |
October 14 2025 11:02:18. |
0644 |
|
|
| Kwality Amritsar Unit II GMP Closure letter zimbab.pdf |
72.62 KB |
October 14 2025 11:02:18. |
0644 |
|
|
| Kwality Kangra Unit I GMP closure letter zimbabwe.pdf |
73.67 KB |
October 14 2025 11:02:18. |
0644 |
|
|
| Kwality Pharma.pdf |
286.66 KB |
February 14 2026 08:49:00. |
0644 |
|
|
| Kwality Pharmaceuticals Ltd-Kangra zimbabwe.pdf |
74.22 KB |
October 14 2025 11:02:18. |
0644 |
|
|
| Kwality Pharmaceuticals Ltd. Company Brochure.pdf |
20.41 MB |
October 14 2025 05:30:46. |
0644 |
|
|
| Kwality Pharmaceuticals_INGUR_000010_GenericCertif.pdf |
1.75 MB |
July 19 2025 11:58:35. |
0644 |
|
|
| LIBYA-GMP-ACCREDITATION(1)(1).pdf |
1.71 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| LIBYA-GMP-ACCREDITATION(1).pdf |
1.71 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| LIBYA-GMP-ACCREDITATION(2).pdf |
1.71 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| LIBYA-GMP-ACCREDITATION.pdf |
1.71 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| LIST OF READY CTD DOSSIERS (1).pdf |
375.07 KB |
July 15 2025 07:57:30. |
0644 |
|
|
| LIST OF READY CTD DOSSIERS (PDF.pdf |
375.36 KB |
July 15 2025 07:17:30. |
0644 |
|
|
| LIST OF READY CTD DOSSIERS(1)(1).xlsx |
33.63 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| LIST OF READY CTD DOSSIERS(1).xlsx |
33.63 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| LIST OF READY CTD DOSSIERS(2).xlsx |
33.63 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| LIST OF READY CTD DOSSIERS.xlsx |
33.63 KB |
January 15 2024 11:22:59. |
0644 |
|
|
| Leaflet-of-Remdesivir-for-Injection-100mg(1)(1).pdf |
2.49 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| Leaflet-of-Remdesivir-for-Injection-100mg(1).pdf |
2.49 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| Leaflet-of-Remdesivir-for-Injection-100mg(2).pdf |
2.49 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| Leaflet-of-Remdesivir-for-Injection-100mg.pdf |
2.49 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| Leaflet-of-Remdesivir-for-Injection-150mg(1)(1).pdf |
447.94 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Leaflet-of-Remdesivir-for-Injection-150mg(1).pdf |
447.94 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| Leaflet-of-Remdesivir-for-Injection-150mg(2).pdf |
447.94 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Leaflet-of-Remdesivir-for-Injection-150mg.pdf |
447.94 KB |
June 23 2022 11:06:13. |
0644 |
|
|
| New Product List (1).pdf |
364.03 KB |
July 15 2025 07:17:29. |
0644 |
|
|
| New Product List(1)(1).xls |
637.50 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| New Product List(1).xls |
637.50 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| New Product List(2).xls |
637.50 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| New Product List.xls |
637.50 KB |
January 15 2024 11:22:34. |
0644 |
|
|
| ONCOLOGY PRODUCT LIST 03.07.2024(1)(1).xlsx |
15.52 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| ONCOLOGY PRODUCT LIST 03.07.2024(1).xlsx |
15.52 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| ONCOLOGY PRODUCT LIST 03.07.2024(2).xlsx |
15.52 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| ONCOLOGY PRODUCT LIST 03.07.2024.pdf |
506.01 KB |
July 15 2025 07:17:30. |
0644 |
|
|
| ONCOLOGY PRODUCT LIST 03.07.2024.xlsx |
15.52 KB |
July 10 2024 10:36:18. |
0644 |
|
|
| PICS Beta Current(1).pdf |
107.11 KB |
July 19 2025 11:55:42. |
0644 |
|
|
| PICS GN Current(1).pdf |
168.39 KB |
July 19 2025 11:55:43. |
0644 |
|
|
| Remdesivir-150mg-label(1)(1).pdf |
819.80 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Remdesivir-150mg-label(1).pdf |
819.80 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| Remdesivir-150mg-label(2).pdf |
819.80 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| Remdesivir-150mg-label.pdf |
819.80 KB |
June 23 2022 11:06:13. |
0644 |
|
|
| THERAPEUTIC-CATEGORY-WISE-PRODUCT-LIST(1)(1).xlsx |
255.08 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| THERAPEUTIC-CATEGORY-WISE-PRODUCT-LIST(1).xlsx |
255.08 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| THERAPEUTIC-CATEGORY-WISE-PRODUCT-LIST(2).xlsx |
255.08 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| THERAPEUTIC-CATEGORY-WISE-PRODUCT-LIST.xlsx |
255.08 KB |
June 23 2022 11:06:13. |
0644 |
|
|
| Thia-GMP_22.04.27.pdf |
508.14 KB |
October 14 2025 11:02:18. |
0644 |
|
|
| Updated-WHO-GMP-2021-2024(1)(1).pdf |
1.18 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| Updated-WHO-GMP-2021-2024(1).pdf |
1.18 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| Updated-WHO-GMP-2021-2024(2).pdf |
1.18 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| Updated-WHO-GMP-2021-2024.pdf |
1.18 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| WHO Certificate Cepha & Onco(1)(1).pdf |
1.24 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| WHO Certificate Cepha & Onco(1).pdf |
1.24 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| WHO Certificate Cepha & Onco(2).pdf |
1.24 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| WHO Certificate Cepha & Onco.pdf |
1.24 MB |
November 15 2023 05:03:37. |
0644 |
|
|
| WHO- GMP-11.03.2021(1)(1).pdf |
1.62 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| WHO- GMP-11.03.2021(1).pdf |
1.62 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| WHO- GMP-11.03.2021(2).pdf |
1.62 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| WHO- GMP-11.03.2021.pdf |
1.62 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| WHO-Certificate-Cytotoxic-Block(1)(1).pdf |
1.19 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| WHO-Certificate-Cytotoxic-Block(1).pdf |
1.19 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| WHO-Certificate-Cytotoxic-Block(2).pdf |
1.19 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| WHO-Certificate-Cytotoxic-Block.pdf |
1.19 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| all mab list.xlsx |
12.93 KB |
June 12 2026 05:01:59. |
0644 |
|
|
| all-certificates(1)(1).pdf |
4.41 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| all-certificates(1).pdf |
4.41 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| all-certificates(2).pdf |
4.41 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| all-certificates.pdf |
4.41 MB |
August 17 2022 11:26:31. |
0644 |
|
|
| company broucher(1).pdf |
23.27 MB |
October 11 2025 07:53:37. |
0644 |
|
|
| company broucher.pdf |
23.27 MB |
September 20 2025 07:55:54. |
0644 |
|
|
| evoting(1)(1).pdf |
345.79 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| evoting(1).pdf |
345.79 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| evoting(2).pdf |
345.79 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| evoting.pdf |
345.79 KB |
June 23 2022 11:06:13. |
0644 |
|
|
| iraq gmp(1)(1).pdf |
158.30 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| iraq gmp(1).pdf |
158.30 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| iraq gmp(2).pdf |
158.30 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| iraq gmp.pdf |
158.30 KB |
March 30 2024 10:23:57. |
0644 |
|
|
| revised anual report 2020-21(1)(1).pdf |
2.33 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| revised anual report 2020-21(1).pdf |
2.33 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| revised anual report 2020-21(2).pdf |
2.33 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| revised anual report 2020-21.pdf |
2.33 MB |
June 23 2022 11:06:13. |
0644 |
|
|
| topbar(1)(1).php |
1.76 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| topbar(1).php |
1.76 KB |
August 30 2024 05:35:05. |
0644 |
|
|
| topbar(2).php |
1.76 KB |
August 30 2024 05:35:37. |
0644 |
|
|
| topbar.php |
1.76 KB |
June 23 2022 11:06:13. |
0644 |
|
|
| voting(1)(1).pdf |
272.11 KB |
August 30 2024 05:35:37. |
0755 |
|
|
| voting(1).pdf |
272.11 KB |
August 30 2024 05:35:05. |
0755 |
|
|
| voting(2).pdf |
272.11 KB |
August 30 2024 05:35:37. |
0755 |
|
|
| voting.pdf |
272.11 KB |
May 24 2023 08:11:14. |
0755 |
|
|
| who-GMP-11-03-2021(1)(1).pdf |
1.62 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| who-GMP-11-03-2021(1).pdf |
1.62 MB |
August 30 2024 05:35:05. |
0644 |
|
|
| who-GMP-11-03-2021(2).pdf |
1.62 MB |
August 30 2024 05:35:37. |
0644 |
|
|
| who-GMP-11-03-2021.pdf |
1.62 MB |
June 23 2022 11:06:13. |
0644 |
|
|